Below is a breakdown of more than 70 studies published in 2026 covering cannabis and compounds such as CBD, THC and CBG. The findings span pain relief, cancer, brain injury, sleep, metabolism, inflammation, wound healing and industrial hemp applications, underscoring just how broad the field has become. The title of each section below links to a full article on The Marijuana Herald.
Clinical Trial: Cannabis-Based Herbal Formula Matches Lorazepam for Chronic Insomnia Relief
A clinical trial found that a cannabis-based herbal formula performed similarly to lorazepam in relieving chronic insomnia, while also showing potential benefits for sleep quality and related symptoms.
Hemp Seed Compounds Show Potential for Treating Diabetes and Obesity
Researchers found that two hemp seed hull compounds, Cannabisin A and Cannabisin B, improved blood sugar control and restored key metabolic signaling tied to diabetes and obesity in cell, liver and mouse models.
Study: CBD Triggers Cell Death in Breast Cancer Cells Through Multiple Molecular Pathways
A new study found that CBD reduced breast cancer cell viability and triggered cell death through several interconnected pathways involving oxidative stress, mitochondrial dysfunction and apoptosis.
CBG-Dominant Cannabis Extract Reduces Fat Cell Formation and Boosts Fat Burning
Researchers found that a CBG-dominant cannabis extract reduced the formation of fat cells while increasing markers tied to fat breakdown and energy expenditure in a lab model.
Exosome-Based Oral CBD Slows Aggressive Triple-Negative Breast Cancer
A study published in Cancer Letters found that an exosome-based oral CBD formulation improved tumor targeting and slowed the growth of aggressive triple-negative breast cancer in mice, while also altering the activity of more than 1,000 genes tied to cancer progression.
Marijuana Flower Shows Neuroprotective and Pain-Relieving Effects in Alzheimer’s Model
A study published in Frontiers in Pharmacology found that marijuana flower produced strong pain-relieving and neuroprotective effects in an animal model designed to mimic both Alzheimer’s-related cognitive impairment and chronic neuropathic pain.
Multiple Cannabis Compounds Found to Target Key Skin Cancer Growth Pathways
A new study found that numerous cannabis-derived compounds may interfere with major skin cancer growth pathways tied to proliferation, invasion and metastasis.
Marijuana Use Linked to Lower Opioid Need After Wrist Fracture Surgery
New research published in the Journal of Surgical Orthopaedic Advances found that patients who used marijuana required significantly fewer opioids after distal radius fracture surgery while reporting pain control comparable to non-users.
CBD-Derived Compound Shows Potential to Treat Bladder Dysfunction After Spinal Cord Injury
A study published in Life Sciences found that the CBD-derived compound CIAC001 improved bladder function, reduced neuroinflammation and helped restore bladder-related nerve pathways in mice with spinal cord injury.
THC and CBD Combination Reduces Pain, Improves Jaw Function in Patients With Chronic TMD
A study in adults with chronic temporomandibular disorder found that a balanced THC/CBD treatment significantly reduced pain and improved jaw mobility, with functional pain falling by roughly 90%.
What Marijuana’s Move to Schedule III Will and Will Not Change Under Federal Law
A new policy analysis found that moving marijuana to Schedule III would mark the biggest federal marijuana policy shift in decades, but it would still fall well short of legalization and would not automatically make state markets federally lawful.
Hemp Protein Cuts Cholesterol by Nearly 40% in Lab Tests
A new study found that a modified hemp protein reduced total cholesterol by nearly 40% and triglycerides by more than 30% in lab testing, while also increasing HDL cholesterol.
